DK1279665T3 - Fremgangsmåde til fremstilling af perindopril, analoge forbindelser og salte heraf ved anvendelse af 2,5-dioxo-oxazolidin-mellemforbindelser - Google Patents
Fremgangsmåde til fremstilling af perindopril, analoge forbindelser og salte heraf ved anvendelse af 2,5-dioxo-oxazolidin-mellemforbindelserInfo
- Publication number
- DK1279665T3 DK1279665T3 DK02016262T DK02016262T DK1279665T3 DK 1279665 T3 DK1279665 T3 DK 1279665T3 DK 02016262 T DK02016262 T DK 02016262T DK 02016262 T DK02016262 T DK 02016262T DK 1279665 T3 DK1279665 T3 DK 1279665T3
- Authority
- DK
- Denmark
- Prior art keywords
- perindopril
- dioxo
- salts
- preparation
- analogous compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/44—Two oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C227/14—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof
- C07C227/18—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions involving amino or carboxyl groups, e.g. hydrolysis of esters or amides, by formation of halides, salts or esters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/022—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
- C07K5/0222—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cardiology (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Indole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Cephalosporin Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP01500197 | 2001-07-24 | ||
EP02016262A EP1279665B1 (en) | 2001-07-24 | 2002-07-23 | A process for the preparation of perindopril, its analogous compounds and salts thereof using 2,5-dioxo-oxazolidine intermediate compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1279665T3 true DK1279665T3 (da) | 2008-06-23 |
Family
ID=8183486
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK02016262T DK1279665T3 (da) | 2001-07-24 | 2002-07-23 | Fremgangsmåde til fremstilling af perindopril, analoge forbindelser og salte heraf ved anvendelse af 2,5-dioxo-oxazolidin-mellemforbindelser |
Country Status (24)
Country | Link |
---|---|
US (1) | US20040248814A1 (da) |
EP (1) | EP1279665B1 (da) |
JP (1) | JP4083118B2 (da) |
KR (1) | KR100694528B1 (da) |
CN (1) | CN100503568C (da) |
AR (1) | AR036187A1 (da) |
AT (1) | ATE386717T1 (da) |
AU (1) | AU2002328954B2 (da) |
BR (1) | BR0211422A (da) |
CY (1) | CY1107403T1 (da) |
DE (1) | DE60225092T2 (da) |
DK (1) | DK1279665T3 (da) |
EA (1) | EA007000B1 (da) |
ES (1) | ES2300402T3 (da) |
HK (1) | HK1067129A1 (da) |
HU (1) | HUP0202414A3 (da) |
MX (1) | MXPA04000649A (da) |
NO (1) | NO20040278L (da) |
NZ (1) | NZ530578A (da) |
PL (1) | PL355161A1 (da) |
PT (1) | PT1279665E (da) |
SI (1) | SI1279665T1 (da) |
WO (1) | WO2003010142A2 (da) |
ZA (1) | ZA200400323B (da) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SI1333026T1 (sl) | 2002-01-30 | 2007-10-31 | Servier Lab | Postopek priprave perindoprila visoke äśistoäśe in intermediatov uporabnih v sintezi |
DK1603558T3 (da) | 2003-02-28 | 2008-09-01 | Servier S A Lab | Fremgangsmåde til fremstilling af perindopril og salte deraf |
US7173004B2 (en) | 2003-04-16 | 2007-02-06 | Bristol-Myers Squibb Company | Macrocyclic isoquinoline peptide inhibitors of hepatitis C virus |
SI21506A (sl) * | 2003-05-08 | 2004-12-31 | LEK farmacevtska dru�ba d.d. | Postopek za pripravo perindoprila |
SI21507A (sl) | 2003-05-16 | 2004-12-31 | LEK farmacevtska dru�ba d.d. | Postopek za pripravo spojin z ace inhibitornim delovanjem |
AU2003263584A1 (en) * | 2003-08-21 | 2005-03-10 | Hetero Drugs Limited | Process for pure perindopril tert-butylamine salt |
ES2336554T3 (es) * | 2003-10-21 | 2010-04-14 | Les Laboratoires Servier | Nuevo metodo para la preparacion de perindopril erbumina cristalina. |
SI21703A (en) * | 2004-01-14 | 2005-08-31 | Lek Farmacevtska Druzba Dd | Inclusion complexes of perindopril, procedure of their preparation, pharmaceutical compositions containing these complexes and their application in treatment of hypertensia |
SI21881A (sl) | 2004-10-15 | 2006-04-30 | Diagen, Smartno Pri Ljubljani, D.O.O. | Nove kristalne oblike perindopril erbumin hidratov, postopek za njihovo pripravo in farmacevtske oblike, ki vsebujejo te spojine |
ES2255872B1 (es) * | 2004-12-31 | 2007-08-16 | Quimica Sintetica, S.A. | Procedimiento para la preparacion de perindopril erbumina. |
US7291745B2 (en) | 2005-03-21 | 2007-11-06 | Glenmark Pharmaceuticals Limited | Process for the preparation of perindopril |
JP2006290825A (ja) * | 2005-04-13 | 2006-10-26 | Shiono Chemical Co Ltd | アルファ型ペリンドプリルエルブミンの製造法 |
WO2006137082A1 (en) * | 2005-06-23 | 2006-12-28 | Ramesh Babu Potluri | Process for industrially viable preparation of perindopril erbumine |
FR2894825B1 (fr) * | 2005-12-21 | 2010-12-03 | Servier Lab | Nouvelle association d'un inhibiteur du courant if sinusal et d'un inhibiteur de l'enzyme de conversion et les compositions pharmaceutiques qui la contiennent |
US7960558B2 (en) | 2006-05-12 | 2011-06-14 | Egis Gyogyszergyar Nyilvanosan Mukodo Reszvenytarsasag | Pharmaceutical intermediate for synthesizing ACE inhibitors and the use thereof |
JP2008019214A (ja) * | 2006-07-13 | 2008-01-31 | Shiono Chemical Co Ltd | ペリンドプリルまたはその誘導体の製造方法 |
SI2150538T1 (sl) | 2007-06-06 | 2012-07-31 | Dsm Sinochem Pharmaceuticals Nl B V | Novi substituirani hidantoini |
FR2985512B1 (fr) * | 2012-01-05 | 2014-06-20 | Servier Lab | Procede de preparation du sel de l-arginine du perindopril |
FR3050380B1 (fr) | 2016-04-20 | 2020-07-10 | Les Laboratoires Servier | Composition pharmaceutique comprenant un betabloquant, un inhibiteur de l'enzyme de conversion et un antihypertenseur ou un ains. |
CN111116709B (zh) * | 2019-12-31 | 2022-06-24 | 北京鑫开元医药科技有限公司 | 一种培哚普利制备方法 |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4508729A (en) * | 1979-12-07 | 1985-04-02 | Adir | Substituted iminodiacids, their preparation and pharmaceutical compositions containing them |
FR2487829A2 (fr) * | 1979-12-07 | 1982-02-05 | Science Union & Cie | Nouveaux imino acides substitues, leurs procedes de preparation et leur emploi comme inhibiteur d'enzyme |
US4350704A (en) * | 1980-10-06 | 1982-09-21 | Warner-Lambert Company | Substituted acyl derivatives of octahydro-1H-indole-2-carboxylic acids |
LU88621I2 (fr) * | 1980-10-23 | 1995-09-01 | Schering Corp | Sandopril |
ZA817261B (en) * | 1980-10-23 | 1982-09-29 | Schering Corp | Carboxyalkyl dipeptides,processes for their production and pharmaceutical compositions containing them |
US4558038A (en) * | 1981-03-30 | 1985-12-10 | Usv Pharmaceutical Corp. | N-Substituted-amindo-amino acids |
US4496542A (en) | 1981-03-30 | 1985-01-29 | Usv Pharmaceutical Corporation | N-substituted-amido-amino acids |
US4686295A (en) * | 1982-03-10 | 1987-08-11 | Usv Pharmaceutical Corporation | N-carboxy anhydride intermediates |
US4885293A (en) * | 1984-09-24 | 1989-12-05 | Schering Corporation | Antiglaucoma agents |
JPS6248696A (ja) * | 1985-08-27 | 1987-03-03 | Kanegafuchi Chem Ind Co Ltd | N−〔1(s)−エトキシカルボニル−3−フエニルプロピル〕−l−アラニル−l−プロリンの製造法 |
ES2004804A6 (es) * | 1987-08-13 | 1989-02-01 | Pharma Investi S A | Un procedimiento para preparar derivados de carboxialquildipeptidos |
FR2620699B1 (fr) * | 1987-09-17 | 1990-06-01 | Adir | Procede de synthese d'alpha amino acides n alkyles et de leurs esters. application a la synthese de carboxyalkyl dipeptides |
FR2620700B1 (fr) * | 1987-09-17 | 1990-06-01 | Adir | Procede de synthese d'alpha amino acides n alkyles et leurs esters. application a la synthese de carboxyalkyl dipeptides |
FR2620703B1 (fr) * | 1987-09-17 | 1991-10-04 | Adir | Procede de synthese industrielle de l'acide perhydroindole carboxylique - 2(2s, 3as, 7as). application a la synthese de carboxyalkyl dipeptides |
FR2620709B1 (fr) * | 1987-09-17 | 1990-09-07 | Adir | Procede de synthese industrielle du perindopril et de ses principaux intermediaires de synthese |
US5258525A (en) * | 1991-03-27 | 1993-11-02 | Mcneilab, Inc. | Processes for preparing [2S-(2α,3aβ,7aβ)]octahydro-1H-indole-2-carboxylic acid and esters |
SI9200213A (en) * | 1992-09-16 | 1994-03-31 | Krka | Process for preparing alkyl-l-alanil-l-proline derivates |
IN184759B (da) | 1997-07-22 | 2000-09-23 | Kaneka Corp | |
SE0000382D0 (sv) * | 2000-02-07 | 2000-02-07 | Astrazeneca Ab | New process |
-
2002
- 2002-07-22 AR ARP020102743A patent/AR036187A1/es not_active Application Discontinuation
- 2002-07-23 HU HU0202414A patent/HUP0202414A3/hu unknown
- 2002-07-23 DE DE60225092T patent/DE60225092T2/de not_active Revoked
- 2002-07-23 DK DK02016262T patent/DK1279665T3/da active
- 2002-07-23 AT AT02016262T patent/ATE386717T1/de active
- 2002-07-23 JP JP2003515501A patent/JP4083118B2/ja not_active Expired - Fee Related
- 2002-07-23 MX MXPA04000649A patent/MXPA04000649A/es active IP Right Grant
- 2002-07-23 EP EP02016262A patent/EP1279665B1/en not_active Revoked
- 2002-07-23 WO PCT/EP2002/008223 patent/WO2003010142A2/en active Application Filing
- 2002-07-23 CN CNB028143221A patent/CN100503568C/zh not_active Expired - Fee Related
- 2002-07-23 BR BR0211422-4A patent/BR0211422A/pt not_active IP Right Cessation
- 2002-07-23 PL PL02355161A patent/PL355161A1/xx not_active Application Discontinuation
- 2002-07-23 KR KR1020047001019A patent/KR100694528B1/ko not_active IP Right Cessation
- 2002-07-23 NZ NZ530578A patent/NZ530578A/en not_active IP Right Cessation
- 2002-07-23 PT PT02016262T patent/PT1279665E/pt unknown
- 2002-07-23 US US10/484,672 patent/US20040248814A1/en not_active Abandoned
- 2002-07-23 EA EA200400129A patent/EA007000B1/ru not_active IP Right Cessation
- 2002-07-23 SI SI200230668T patent/SI1279665T1/sl unknown
- 2002-07-23 AU AU2002328954A patent/AU2002328954B2/en not_active Ceased
- 2002-07-23 ES ES02016262T patent/ES2300402T3/es not_active Expired - Lifetime
-
2004
- 2004-01-15 ZA ZA2004/00323A patent/ZA200400323B/en unknown
- 2004-01-21 NO NO20040278A patent/NO20040278L/no not_active Application Discontinuation
-
2005
- 2005-01-19 HK HK05100509.9A patent/HK1067129A1/xx unknown
-
2008
- 2008-04-21 CY CY20081100440T patent/CY1107403T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
PT1279665E (pt) | 2008-03-28 |
MXPA04000649A (es) | 2004-10-27 |
WO2003010142A3 (en) | 2003-08-28 |
CN1529694A (zh) | 2004-09-15 |
EA200400129A1 (ru) | 2004-08-26 |
NZ530578A (en) | 2007-02-23 |
BR0211422A (pt) | 2004-08-17 |
JP4083118B2 (ja) | 2008-04-30 |
ATE386717T1 (de) | 2008-03-15 |
HK1067129A1 (en) | 2005-04-01 |
HU0202414D0 (da) | 2002-09-28 |
KR100694528B1 (ko) | 2007-03-13 |
NO20040278L (no) | 2004-01-21 |
EP1279665B1 (en) | 2008-02-20 |
CY1107403T1 (el) | 2012-12-19 |
HUP0202414A2 (hu) | 2003-02-28 |
EP1279665A3 (en) | 2003-03-12 |
DE60225092T2 (de) | 2009-02-19 |
SI1279665T1 (sl) | 2008-06-30 |
WO2003010142A2 (en) | 2003-02-06 |
AU2002328954B2 (en) | 2007-10-04 |
KR20040029378A (ko) | 2004-04-06 |
JP2005501829A (ja) | 2005-01-20 |
US20040248814A1 (en) | 2004-12-09 |
CN100503568C (zh) | 2009-06-24 |
PL355161A1 (en) | 2003-01-13 |
AR036187A1 (es) | 2004-08-18 |
HUP0202414A3 (en) | 2003-05-28 |
DE60225092D1 (de) | 2008-04-03 |
ES2300402T3 (es) | 2008-06-16 |
EA007000B1 (ru) | 2006-06-30 |
EP1279665A2 (en) | 2003-01-29 |
ZA200400323B (en) | 2005-03-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1279665T3 (da) | Fremgangsmåde til fremstilling af perindopril, analoge forbindelser og salte heraf ved anvendelse af 2,5-dioxo-oxazolidin-mellemforbindelser | |
DK1312406T3 (da) | Fremgangsmåde til rensning af syntesegas | |
DK1163207T3 (da) | Forbedret fremgangsmåde til fremstillingen af ikke-hygroskopiske salte af L(-)-carnitin | |
DK1277722T3 (da) | Fremgangsmåde til fremstilling af methanol | |
DK1044969T3 (da) | Fremgangsmåde og mellemprodukter til fremstilling af anti-cancer forbindelser | |
DK1296935T3 (da) | Fremgangsmåde til fremstilling af substituerede octanoylamider | |
DK1232152T3 (da) | Forbedret fremgangsmåde til fremstilling af nitrogensubstituerede aminotetraliner | |
DK1527035T3 (da) | Kontinuerlig fremgangsmåde til alkyleringen af carbonhydrider | |
DK1383733T3 (da) | Fremgangsmåde til fremstilling af 1,3-substituerede indener og aryl-sammenföjede azapolycykliske forbindelser | |
DK0937055T3 (da) | Fremgangsmåde til fremstilling af d,I-alfa-tocopherol | |
DK1392318T3 (da) | 15-keto-prostaglandiner til behandling af lægemiddelinduceret forstoppelse | |
DK1385826T3 (da) | Fremgangsmåde til fremstilling af (S)-(+)- og (R)-(-)-10,11-dihydro-10-hydroxy-5H-dibenz/b,f/azapin-5-carboxamid | |
DK0923978T3 (da) | Fremgangsmåde til behandling af röggas | |
DK1206436T3 (da) | Retinoider til behandling af emfysem | |
NO20033433L (no) | Fremgangsmåte for fremstilling av 2-(2-pyridylmetyl)sulfinyl- 1H-benzimidasol | |
DK0994115T3 (da) | Fremgangsmåde til fremstilling af pyrazolo-(4,3-d)pyrimidin-7-oner og mellemprodukter deraf | |
NO331195B1 (no) | Fremgangsmate for fremstilling av halogen-substituerte monosulfider og deres hydroksymonosulfid-evkivalenter som mellomprodukter. | |
DK1441726T3 (da) | Derivater af phenoxy-N' -4-(isothiazolidin-1,1-dioxid-2-yl)phenyl]-valerianesyreamid og andre forbindelser som inhibitorer af koagulationsfaktoren Xa til behandling af thromboemboliske lidelser og tumorer | |
DK1373232T3 (da) | Fremgangsmåde til fremstilling af N-substituerede 2,6-dialkylmorpholiner | |
DK0862939T3 (da) | Fremgangsmåde til behandling af röggas | |
DK1503995T3 (da) | Fremgangsmåde til fremstilling af substituerede phenylsulfonylurinstoffer | |
DK1075473T3 (da) | Fremgangsmåde til fremstilling af 1,3-disubstituerede-4-oxocykliske urinstoffer | |
IS5654A (is) | Aðferð til framleiðslu á pýrazóló[4,3-d]pýrimidín-7-ón-3-pýridýlsúlfónýl efnasamböndum og milliefnum af þeim | |
NO20035395D0 (no) | Fremgangsmåte for fremstilling av paraffiniske mellomdestillater | |
DK1177165T3 (da) | Fremgangsmåde til fremstilling af pesticidmellemprodukter |